Astrazeneca Share News (AZN)

LONDON MARKET CLOSE: Tepid close after quiet day with US market closed

(Alliance News) - Stocks in London were largely higher on Tuesday, though the FTSE 100 slipped into the red amid weakness, while US markets were shut for the independence day holiday.

LONDON MARKET MIDDAY: Stocks higher amid US holiday-thinned trade

(Alliance News) - Stock prices in London were higher at midday on Tuesday, with the absence of US markets and any major economic releases keeping trade muted.

LONDON BROKER RATINGS: Dunelm, AstraZeneca and Persimmon cut

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

AstraZeneca shares fall as lung cancer results not as strong as hoped

(Alliance News) - AstraZeneca PLC on Monday saw shares fall, as test results suggested a new lung cancer drug may be less successful than hoped, despite being generally positive.

FTSE 100 inches lower as healthcare drags; miners rise

AstraZeneca down as lung cancer drug trial lags expectations

*

European shares end lower as healthcare declines outweigh miner gains

STOXX 600 snaps four-day winning streak

*

LONDON MARKET CLOSE: Blue chips lose early shine as US treads water

(Alliance News) - London's FTSE 100 ran out of steam on Monday to close little changed, while New York markets made a muted start to an abbreviated session ahead of Independence Day.

Will UK stocks fare better as tech rally fades?

STOXX 600 up 0.1%

*

LONDON MARKET MIDDAY: Miners and oil majors lead FTSE 100 march

(Alliance News) - European equities went into Monday afternoon on the up, with the FTSE 100 outperforming as it was supported by its natural resources sector and oil majors.

The most anticipated recession is also the most postponed

STOXX 600 up 0.2%

*

AstraZeneca shares drop as lung cancer trial update lags expectations

July 3 (Reuters) - AstraZeneca said on Monday an experimental precision drug slowed progression of lung cancer in a late-stage trial, but the company's shares fell as much as 6% as analysts said the benefits may not be as pronounced as hoped.

LONDON MARKET OPEN: Stocks start second half in green amid PMIs

(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York,

TOP NEWS: AstraZeneca, Daiichi hail datopotamab lung cancer trial

(Alliance News) - AstraZeneca PLC and Tokyo-based partner Daiichi Sankyo Co Ltd on Monday announced that their investigational antibody drug conjugate Datopotamab deruxtecan showed positive results in an advanced non-small cell lung cancer trial.

AstraZeneca reveals mixed interim findings in lung cancer trial

(Sharecast News) - AstraZeneca announced on Monday that datopotamab deruxtecan, or 'Dato-DXd', has shown promising results in a trial in patients with locally-advanced or metastatic non-small cell lung cancer (NSCLC) who had previously received at least one therapy.

IN BRIEF: AstraZeneca invests USD400 million in reforestation

AstraZeneca PLC - Cambridge-based pharmaceutical company - Announces USD400 million investment in global AZ Forest programme, aiming to plant 50 million trees by the end of 2025 and 200 million trees by 2030. Projects are in Brazil, India, Vietnam, Ghana and Rwanda. The programme is focused on reforestation, biodiversity and community resilience and spans over 100,000 hectares worldwide.